Last reviewed · How we verify

NCT04287634

Comparison Between the Segmental Mobilization and Entire Segmental Spine Mobilization in Cervical Spondylosis

Completed NA Last updated 2 March 2020
What this trial tests

NA trial testing Segmental Mobilization in Cervical Spondylosis in 30 participants. Completed in 14 July 2018.

Timeline
1 March 2018
Primary endpoint
30 June 2018
14 July 2018

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment30
Start date1 March 2018
Primary completion30 June 2018
Estimated completion14 July 2018
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 30 to 60, any sex, with Cervical Spondylosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

All the patients of cervical spondylosis which were enrolled in this study were assessed in Rehabilitation centre of Yusra General Hospital. Patients who compete the inclusion criteria are randomly assigned by the seal envelop method in to two groups interventional and control group. There is nine sessions of three weeks rehabilitation program and Pain is assessed on Numeric pain rating scale, Disability on Neck Disability index and ROM is assessed by Goniometer in 1ST, 4TH and last visit. Three sessions of intervention is given to patient per week.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Segmental Mobilization

Trials testing the same drug.

Other recruiting trials for Cervical Spondylosis

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04287634.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing